A predictive model for longitudinal cognitive subtypes in Parkinson's disease
- 8 January 2025
- journal article
- research article
- Published by Springer Nature in Neurological Sciences
- Vol. 46 (6) , 2627-2635
Abstract
Background Longitudinal cognitive changes in Parkinson’s disease (PD) exhibit considerable heterogeneity.Predicting cognitive trajectories in early PD patients can improve prognostic counseling and guide clinical trials. Methods This study included 337 early PD patients with 6-year follow-up in the Parkinson's Progression Markers Initiative (PPMI) database.Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA) to identify subtypes of longitudinal cognitive trajectories, and a nomogram predictive model was constructed using baseline clinical variables. Results The 337 PD patients had a mean age of 61.0 years, mean disease duration of 0.55 years, and mean MoCA score of 27.1 points. Latent class mixed models (LCMM) identified two longitudinal cognitive subtypes: cognitive stable (276 cases, 81.9%) and cognitivel deteriorating (61 cases, 18.1%). The cognitively deteriorating subtype presented poorer baseline cognition, older age, and more severe motor and non-motor symptoms. On biomarkers, the cognitively deteriorating subtype revealed higher serum NFL levels and lower mean striatum DAT uptake. Six baseline clinical variables (age, Letter Number Sequencing score, Symbol Digit Modalities Test score, Benton Judgment of Line Orientation Test score, Hopkins Verbal Learning Test-Revised score, and REM Sleep Behavior Disorder) were selected to construct the nomogram predictive model which achieved an AUC of 0.92.The calibration curve demonstrated high consistency between predicted and observed probabilities.The predictive model has potential utility in disease-modifying clinical trials by pre-screening patients at high risk for cognitive deterioration. Conclusion This study identified two longitudinal cognitive subtypes: cognitive stable and cognitive deterioration within 6-year follow-up, and eighteen percent of early PD patients shared the cognitive deterioration subtype The predictive model, incorporating six baseline variables could estimate the risk of longitudinal cognitive deterioration in PD.Keywords
Funding Information
- Henan Province Key R&D Program (241111313500)
- Henan Provincial Science and Technology Research Project (LHGJ20230012)
- Henan Academy of Medical Sciences research program (SBGJ20210233)
- Henan Provincial Natural Science Foundation (242300421289)
This publication has 27 references indexed in Scilit:
- Progression of Parkinson's disease patients' subtypes based on cortical thinning: 4-year follow-upParkinsonism & Related Disorders, 2019
- Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)Journal of Neurology, 2019
- Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort studyThe Lancet Neurology, 2017
- Clinical predictors of cognitive impairment and psychiatric complications in Parkinson’s diseaseArquivos de Neuro-Psiquiatria, 2015
- Parkinson’s disease dementia: a neural networks perspectiveBrain, 2015
- Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gaitBrain, 2013
- The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohortJournal of Neurology, Neurosurgery & Psychiatry, 2013
- Cognitive Impairment in Parkinson’s Disease: The Dual Syndrome HypothesisNeurodegenerative Diseases, 2012
- Misuse of the Linear Mixed Model When Evaluating Risk Factors of Cognitive DeclineAmerican Journal of Epidemiology, 2011
- Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's diseaseThe Lancet Neurology, 2010